ZA948191B - Anti-viral agents - Google Patents

Anti-viral agents

Info

Publication number
ZA948191B
ZA948191B ZA948191A ZA948191A ZA948191B ZA 948191 B ZA948191 B ZA 948191B ZA 948191 A ZA948191 A ZA 948191A ZA 948191 A ZA948191 A ZA 948191A ZA 948191 B ZA948191 B ZA 948191B
Authority
ZA
South Africa
Prior art keywords
viral agents
viral
agents
Prior art date
Application number
ZA948191A
Inventor
Washington Odur Dr Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of ZA948191B publication Critical patent/ZA948191B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA948191A 1993-10-19 1994-10-19 Anti-viral agents ZA948191B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents

Publications (1)

Publication Number Publication Date
ZA948191B true ZA948191B (en) 1995-06-08

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948191A ZA948191B (en) 1993-10-19 1994-10-19 Anti-viral agents

Country Status (26)

Country Link
EP (1) EP0739208A1 (en)
JP (1) JPH09505804A (en)
CN (1) CN1140992A (en)
AP (1) AP620A (en)
AU (1) AU7943794A (en)
BG (1) BG100599A (en)
BR (1) BR9407862A (en)
CA (2) CA2123825A1 (en)
CO (1) CO4520283A1 (en)
CZ (1) CZ113796A3 (en)
EE (1) EE9600057A (en)
GB (2) GB9321558D0 (en)
HR (1) HRP940688A2 (en)
HU (1) HUT76322A (en)
IL (1) IL111338A0 (en)
JO (1) JO1866B1 (en)
MA (1) MA23356A1 (en)
MD (1) MD960168A (en)
NO (1) NO961547L (en)
OA (1) OA10579A (en)
PE (1) PE5596A1 (en)
PL (1) PL314008A1 (en)
SK (1) SK50696A3 (en)
UY (1) UY23844A1 (en)
WO (1) WO1995011028A1 (en)
ZA (1) ZA948191B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (en) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd Interferon activity-enhancing agent and antivirus activity-enhancing composition containing the enhancing agent and interferon
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
WO2004043338A2 (en) * 2002-05-10 2004-05-27 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (en) 2002-07-16 2004-01-16 Dayco Europe Srl INTEGRATED PULLEY-TORSIONAL DAMPER GROUP
WO2004013142A1 (en) * 2002-08-02 2004-02-12 The Institute Of Radiation Medicine, Academy Of Miilitary Medical Sciences, People's Liberation Army A riboflavin derivative and its manufacture and uses
EP2545788A1 (en) * 2011-07-13 2013-01-16 Martin Hulliger Dietary multi-component system
JP2018131410A (en) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 Caspase-3 inhibitor and use thereof
BR112020008022A2 (en) * 2017-10-24 2020-10-27 Lunella Biotech, Inc. mitoflavoscines: targeting enzymes containing flavin eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration
US20220257550A1 (en) * 2019-07-09 2022-08-18 Dsm Ip Assets B.V. Reducing the viral activity of elafibranor with riboflavin or dha

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (en) * 1989-09-14 1998-03-11 三井農林株式会社 Influenza virus infection prevention agent
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (en) * 1991-04-02 1995-03-10 Jean Berque NEW THERAPEUTIC INDICATIONS, PARTICULARLY FOR THE TREATMENT OF AIDS, OF AN ALREADY EXISTING MEDICINAL PRODUCT FROM A DENIMOUS MOLECULE OF CONTRAINDICATIONS AND ADVERSE REACTIONS.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (en) * 1992-03-27 2000-08-07 雪印乳業株式会社 Sialic acid-bound 5-deazaflavin compounds

Also Published As

Publication number Publication date
GB2283913A (en) 1995-05-24
HU9601006D0 (en) 1996-06-28
CO4520283A1 (en) 1997-10-15
JO1866B1 (en) 1995-12-27
AP620A (en) 1997-10-14
CA2123825A1 (en) 1995-04-20
WO1995011028A1 (en) 1995-04-27
NO961547D0 (en) 1996-04-18
CN1140992A (en) 1997-01-22
OA10579A (en) 2002-06-19
HRP940688A2 (en) 1997-04-30
CA2174552A1 (en) 1995-04-27
UY23844A1 (en) 1995-03-28
PL314008A1 (en) 1996-08-05
AP9400695A0 (en) 1995-01-31
BR9407862A (en) 1997-05-20
MD960168A (en) 1998-04-30
EP0739208A1 (en) 1996-10-30
AU7943794A (en) 1995-05-08
SK50696A3 (en) 1997-01-08
GB9321558D0 (en) 1993-12-08
EE9600057A (en) 1996-10-15
HUT76322A (en) 1997-08-28
CZ113796A3 (en) 1996-11-13
GB9421099D0 (en) 1994-12-07
IL111338A0 (en) 1994-12-29
PE5596A1 (en) 1996-04-18
BG100599A (en) 1997-02-28
MA23356A1 (en) 1995-07-01
NO961547L (en) 1996-06-19
JPH09505804A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
DE69400639D1 (en) Rehydratationsgetraenk
DE69426415D1 (en) Intrapulmonares hormonabgabesystem
DE69421914D1 (en) Ekg-sensor
DE69401926D1 (en) Hydroxamsäurederivate
EP0699071A4 (en) Anti-viral guanosine-rich oligonucleotides
DE69406448D1 (en) Luftreinigungsgerät
DE69405713D1 (en) Carbonylierungsverfahren
DE69412242D1 (en) Orthopädisches gussmaterial
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
GB9414754D0 (en) Anti-viral agent
DE69423875D1 (en) Hydrodealkylierungsverfahren
GB9421099D0 (en) Anti-viral agents
DE59409705D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
GB9322576D0 (en) Antihaemostatic agents
DE59408644D1 (en) Jacquardmaschine
DE69408437D1 (en) Oxychlorierungsverfahren
DE59408733D1 (en) Metallhalogenidentladungslampe
DE59410065D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
GB9212276D0 (en) Anti-viral agents
DE69407946D1 (en) Oxychlorierungskatalysator
DE69425743D1 (en) Faserreaktive anthrachinon-farbstoffe
DE69410761D1 (en) Polyacetalharzzusammensetzung
DE69412128D1 (en) Kühlcontainer
DE69413832D1 (en) Amidierungskatalysatorkonzentrat
DE59407310D1 (en) Phenylazotriazolopyridinfarbstoffe